Display options
Share it on

Clin Exp Hepatol. 2015 Jun;1(2):35-38. doi: 10.5114/ceh.2015.51805. Epub 2015 Jun 02.

Immune regulation and viral diversity as correlates of natural and treatment induced immune control in persistent hepatitis B virus (HBV) infection.

Clinical and experimental hepatology

Anna Parfieniuk-Kowerda, Jerzy Jaroszewicz, Robert Flisiak

Affiliations

  1. Department of Infectious Diseases and Hepatology, Medical University of Bia?ystok, Poland.

PMID: 28856253 PMCID: PMC5497408 DOI: 10.5114/ceh.2015.51805

Abstract

In long-lasting chronic hepatitis B, the phenomenon of cytotoxic CD8 T lymphocytes (CTL) exhaustion and unresponsiveness to HBV-specific stimuli was shown to be crucial for the loss of immune control of the virus and disease activity. There is evidence that Tregs, Th17 cells and Bregs seem to be important in pathogenesis of the immunological dysfunction and loss of HBV-specific activity of cytotoxic CD8 T-cells. Th17-driven immune response was shown to be important in pathogenesis of acute HBV infection and exacerbated chronic hepatitis B along with Th1 response contributing to hepatocellular damage due to proinflammatory activities of Th17-derived cytokines, mainly IL-17A. Treg cell responses may be either beneficial or harmful in HBV infection by limiting liver immunopathology or suppressing protective T cell responses, thus promoting virus replication and survival. Thus, Treg/Th17 equilibrium seems to be crucial for the outcomes of HBV infection.

Keywords: CD8+ cells; HBV; Th17; Treg; chronic hepatitis B

References

  1. Blood. 2003 Apr 1;101(7):2711-20 - PubMed
  2. Gastroenterology. 2007 Sep;133(3):951-8 - PubMed
  3. Hepatology. 2010 Nov;52(5):1611-20 - PubMed
  4. PLoS One. 2010 Nov 08;5(11):e13869 - PubMed
  5. J Hepatol. 2010 Apr;52(4):508-13 - PubMed
  6. J Hepatol. 2010 Apr;52(4):514-22 - PubMed
  7. PLoS One. 2013;8(3):e58966 - PubMed
  8. Gastroenterology. 2010 Feb;138(2):682-93, 693.e1-4 - PubMed
  9. J Immunol. 2006 Oct 15;177(8):5145-54 - PubMed
  10. Gastroenterology. 2010 Aug;139(2):483-90 - PubMed
  11. Gastroenterology. 2012 Dec;143(6):1576-1585.e4 - PubMed
  12. Gastroenterology. 2007 Sep;133(3):1031-5 - PubMed
  13. PLoS One. 2012;7(6):e39307 - PubMed
  14. J Immunol. 2012 Oct 15;189(8):3925-35 - PubMed
  15. PLoS Pathog. 2011 May;7(5):e1002045 - PubMed
  16. J Hepatol. 2008 Feb;48(2):335-52 - PubMed
  17. PLoS Pathog. 2013;9(6):e1003422 - PubMed
  18. Hepatology. 2005 Apr;41(4):771-8 - PubMed
  19. PLoS Biol. 2004 Feb;2(2):E20 - PubMed
  20. Am J Gastroenterol. 2002 Aug;97(8):2086-92 - PubMed
  21. Gastroenterology. 2008 Jun;134(7):1938-49, 1949.e1-3 - PubMed
  22. J Immunol. 2008 May 1;180(9):5771-7 - PubMed
  23. Hepatology. 2011 May;53(5):1494-503 - PubMed
  24. PLoS One. 2012;7(10 ):e47648 - PubMed
  25. Viral Immunol. 2011 Aug;24(4):303-10 - PubMed

Publication Types